𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allogeneic bone marrow transplantation as primary therapy for chronic myelomonocytic leukemia

✍ Scribed by Forman, S. J. ;O'Donnell, M. R. ;Blume, K. G. ;Feinstein, D. I.

Publisher
Springer-Verlag
Year
1987
Weight
591 KB
Volume
54
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Allogeneic marrow transplantation for ch
Allogeneic marrow transplantation for chronic granulocytic leukemia
✍ Speck, B. ;Gratwohl, A. ;Nissen, C. ;Osterwalder, B. ;MοΏ½ller, M. ;Bannert, P. ;M πŸ“‚ Article πŸ“… 1982 πŸ› Springer-Verlag βš– 314 KB

Six patients with Philadelphia-chromosome (Ph' +)-positive chronic granulocytic leukemia were transplanted from their HLA-identical siblings after conditioning with cyclophosphamide and 1'000 rad total body irradiation. All received cyclosporin-A for prophylaxis of Graft-versus-Host disease. All pat

Porphyria cutanea tarda after allogeneic
Porphyria cutanea tarda after allogeneic bone marrow transplantation for chronic myelogenous leukemia
✍ Dr. D. Guyotat; J. F. Nicolas; F. Augey; D. Fiere; J. Thivolet πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 176 KB πŸ‘ 2 views

A case of porphyria cutanea terda (PCT) occurring after bone marrow transplantation (BMT) is reported. A 43-year-oid male with chronic myelogenous leukemia received an human leukocyte antigen (HLA)-identical allogeneic transplantation with T-cell depleted marrow. Because of graft rejection, a second

Very late relapse of chronic myelogenous
Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation
✍ Arunabh Sekhri; Delong Liu; Muhammad Rasul; Nasir Ahmed; Tauseef Ahmed; Karen Se πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 99 KB

Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow tran